Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer
Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer
Recruiting · NCT07325630 · Registry updated 2026-01-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer | IBI363 + Chemotherapy | Recruiting | Phase 2 | 2026-01-08 | NCT07325630 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhejiang Cancer Hospital | 142 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhejiang Cancer Hospital | Hangzhou | China | 164 |